New Data Presented from EMBLEM(TM) Study for Pipeline Drug Epratuzumab for ... - MarketWatch (press release) PDF Print
MarketWatch (press release)These systems were: musculoskeletal, mucocutaneous, cardiorespiratory, neuropsychiatric, constitutional and renal. "Achieving a BILAG improvement without

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.